Develops drugs for hemorrhagic cystitis and oral lichen planus.
Jun 2025Revenue $470K/yrExpenses $6.07M/yr
No trendCash runway ≈ 5 months from Sep 2025
Figures by year
When will Lipella Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2025, revenue was $470K and expenses $6.07M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2024 | $536K | $5.62M | −$5.08M |
| Dec 2023 | $450K | $5.20M | −$4.75M |
| Dec 2022 | $184K | $2.77M | −$2.59M |
| Dec 2021 | $259K | $2.18M | −$1.92M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.